Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-19

FDA Approved: DULOXETINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for duloxetine hydrochloride from Aurobindo Pharma Limited, granting regulatory clearance for a generic product under th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)

Snippet

SUPPL AP for DULOXETINE (DULOXETINE HYDROCHLORIDE)